Frank Takkinen
Stock Analyst at Lake Street
(0.55)
# 3,948
Out of 4,357 analysts
670
Total ratings
39.4%
Success rate
-1.7%
Average return
Main Sectors:
Stocks Rated by Frank Takkinen
| Stock | Action | Price Target | Current | Upside | Ratings | Updated | |
|---|---|---|---|---|---|---|---|
| CLPT ClearPoint Neuro | Reiterated: Buy | $30 | $12.67 | +136.78% | 44 | May 29, 2026 | |
| TLSI TriSalus Life Sciences | Reiterated: Buy | $8 | $3.41 | +134.60% | 20 | May 29, 2026 | |
| NPCE NeuroPace | Reiterated: Buy | $20 | $16.54 | +20.92% | 48 | May 29, 2026 | |
| HYPR Hyperfine | Reiterated: Buy | $2.5 | $1.56 | +60.26% | 18 | May 27, 2026 | |
| DXR Daxor | Reiterated: Buy | $23 | $10.28 | +123.74% | 5 | May 26, 2026 | |
| BBNX Beta Bionics | Reiterated: Buy | $20 | $12.12 | +65.02% | 11 | May 22, 2026 | |
| ADGM Adagio Medical Holdings | Reiterated: Buy | $4 | $0.724 | +452.49% | 7 | May 21, 2026 | |
| RCEL AVITA Medical | Upgraded: Buy | $3.5 → $6 | $4.33 | +38.57% | 9 | May 15, 2026 | |
| ELUT Elutia | Reiterated: Buy | $5 | $1.15 | +334.78% | 30 | May 15, 2026 | |
| CLBT Cellebrite DI | Reiterated: Buy | $21 | $14.73 | +42.57% | 1 | May 15, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $4 | $1.98 | +102.02% | 38 | May 13, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $32 | $22.79 | +40.41% | 2 | May 13, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $2 | $0.97 | +106.19% | 37 | May 13, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $14 | $5.58 | +150.90% | 43 | May 12, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $10 | $5.80 | +72.41% | 17 | May 11, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $55 → $45 | $22.19 | +102.79% | 34 | May 8, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $50 | $17.20 | +190.70% | 4 | May 8, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $8 | $7.55 | +5.96% | 1 | May 7, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $8 | $4.06 | +97.04% | 34 | May 7, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $110 → $135 | $94.65 | +42.63% | 12 | May 6, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $5 → $4 | $0.9207 | +334.45% | 13 | May 5, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $4 | $1.65 | +142.42% | 17 | Apr 30, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $50 | $39.48 | +26.65% | 13 | Apr 28, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $12 | $4.86 | +146.91% | 25 | Mar 30, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $10 | $3.68 | +171.74% | 6 | Feb 26, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $100 → $120 | $90.66 | +32.36% | 19 | Feb 11, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Buy | $3 → $1.5 | $0.286 | +424.48% | 38 | Feb 10, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $20 → $15 | $8.62 | +74.01% | 9 | Jan 23, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $24 | $11.48 | +109.06% | 4 | Jan 7, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $6 | $0.7055 | +750.46% | 17 | Oct 7, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $150 | $41.36 | +262.67% | 28 | Aug 27, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $2.5 | $4.00 | n/a | 18 | Aug 9, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $10 | $4.32 | n/a | 11 | Jul 22, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $4 | $6.20 | n/a | 6 | May 15, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $22.08 → $19.32 | $9.53 | n/a | 9 | Nov 3, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $150 → $40 | $0.000001 | n/a | 4 | May 31, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Buy | $4 → $12 | $0.131 | n/a | 3 | Feb 14, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Buy | $1 | $3.94 | n/a | 4 | Sep 29, 2022 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Buy | $14 → $10 | $4.30 | n/a | 7 | May 11, 2022 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiated Coverage: Buy | $5.52 | $0.315 | n/a | 1 | Apr 5, 2022 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Downgraded: Hold | $6 → $10 | $0.0001 | n/a | 3 | Mar 31, 2022 |
ClearPoint Neuro
May 29, 2026
Reiterated: Buy
Price Target: $30
Current: $12.67
Upside: +136.78%
TriSalus Life Sciences
May 29, 2026
Reiterated: Buy
Price Target: $8
Current: $3.41
Upside: +134.60%
NeuroPace
May 29, 2026
Reiterated: Buy
Price Target: $20
Current: $16.54
Upside: +20.92%
Hyperfine
May 27, 2026
Reiterated: Buy
Price Target: $2.5
Current: $1.56
Upside: +60.26%
Daxor
May 26, 2026
Reiterated: Buy
Price Target: $23
Current: $10.28
Upside: +123.74%
Beta Bionics
May 22, 2026
Reiterated: Buy
Price Target: $20
Current: $12.12
Upside: +65.02%
Adagio Medical Holdings
May 21, 2026
Reiterated: Buy
Price Target: $4
Current: $0.724
Upside: +452.49%
AVITA Medical
May 15, 2026
Upgraded: Buy
Price Target: $3.5 → $6
Current: $4.33
Upside: +38.57%
Elutia
May 15, 2026
Reiterated: Buy
Price Target: $5
Current: $1.15
Upside: +334.78%
Cellebrite DI
May 15, 2026
Reiterated: Buy
Price Target: $21
Current: $14.73
Upside: +42.57%
May 13, 2026
Reiterated: Buy
Price Target: $4
Current: $1.98
Upside: +102.02%
May 13, 2026
Reiterated: Buy
Price Target: $32
Current: $22.79
Upside: +40.41%
May 13, 2026
Reiterated: Buy
Price Target: $2
Current: $0.97
Upside: +106.19%
May 12, 2026
Reiterated: Buy
Price Target: $14
Current: $5.58
Upside: +150.90%
May 11, 2026
Reiterated: Buy
Price Target: $10
Current: $5.80
Upside: +72.41%
May 8, 2026
Reiterated: Buy
Price Target: $55 → $45
Current: $22.19
Upside: +102.79%
May 8, 2026
Reiterated: Buy
Price Target: $50
Current: $17.20
Upside: +190.70%
May 7, 2026
Reiterated: Buy
Price Target: $8
Current: $7.55
Upside: +5.96%
May 7, 2026
Reiterated: Buy
Price Target: $8
Current: $4.06
Upside: +97.04%
May 6, 2026
Reiterated: Buy
Price Target: $110 → $135
Current: $94.65
Upside: +42.63%
May 5, 2026
Reiterated: Buy
Price Target: $5 → $4
Current: $0.9207
Upside: +334.45%
Apr 30, 2026
Reiterated: Buy
Price Target: $4
Current: $1.65
Upside: +142.42%
Apr 28, 2026
Reiterated: Buy
Price Target: $50
Current: $39.48
Upside: +26.65%
Mar 30, 2026
Reiterated: Buy
Price Target: $12
Current: $4.86
Upside: +146.91%
Feb 26, 2026
Reiterated: Buy
Price Target: $10
Current: $3.68
Upside: +171.74%
Feb 11, 2026
Reiterated: Buy
Price Target: $100 → $120
Current: $90.66
Upside: +32.36%
Feb 10, 2026
Maintained: Buy
Price Target: $3 → $1.5
Current: $0.286
Upside: +424.48%
Jan 23, 2026
Reiterated: Buy
Price Target: $20 → $15
Current: $8.62
Upside: +74.01%
Jan 7, 2026
Reiterated: Buy
Price Target: $24
Current: $11.48
Upside: +109.06%
Oct 7, 2025
Reiterated: Buy
Price Target: $6
Current: $0.7055
Upside: +750.46%
Aug 27, 2025
Reiterated: Buy
Price Target: $150
Current: $41.36
Upside: +262.67%
Aug 9, 2024
Reiterated: Buy
Price Target: $2.5
Current: $4.00
Upside: n/a
Jul 22, 2024
Reiterated: Buy
Price Target: $10
Current: $4.32
Upside: n/a
May 15, 2024
Reiterated: Buy
Price Target: $4
Current: $6.20
Upside: n/a
Nov 3, 2023
Reiterated: Buy
Price Target: $22.08 → $19.32
Current: $9.53
Upside: n/a
May 31, 2023
Reiterated: Buy
Price Target: $150 → $40
Current: $0.000001
Upside: n/a
Feb 14, 2023
Maintained: Buy
Price Target: $4 → $12
Current: $0.131
Upside: n/a
Sep 29, 2022
Maintained: Buy
Price Target: $1
Current: $3.94
Upside: n/a
May 11, 2022
Maintained: Buy
Price Target: $14 → $10
Current: $4.30
Upside: n/a
Apr 5, 2022
Initiated Coverage: Buy
Price Target: $5.52
Current: $0.315
Upside: n/a
Mar 31, 2022
Downgraded: Hold
Price Target: $6 → $10
Current: $0.0001
Upside: n/a